Hookipa Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Hookipa Pharma
HOOK Stock  USD 0.90  0.01  1.12%   
Analyzing historical trends in various income statement and balance sheet accounts from Hookipa Pharma's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Hookipa Pharma's valuation are summarized below:
Gross Profit
-50.5 M
Market Capitalization
11 M
Enterprise Value Revenue
1.9077
Revenue
9.4 M
Earnings Share
(4.83)
There are currently one hundred twenty fundamental trends for Hookipa Pharma that can be evaluated and compared over time across competitors. We recommend to confirm Hookipa Pharma's regular fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 27.5 M. Enterprise Value is expected to rise to about (14.9 M) this year

Hookipa Pharma Total Revenue

53.06 Million

Check Hookipa Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hookipa Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 4.5 M, Interest Income of 4.5 M or Depreciation And Amortization of 2.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.64. Hookipa financial statements analysis is a perfect complement when working with Hookipa Pharma Valuation or Volatility modules.
  
Build AI portfolio with Hookipa Stock
Check out the analysis of Hookipa Pharma Correlation against competitors.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.

Hookipa Pharma Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets139.4 M94.9 M103.8 M
Slightly volatile
Short and Long Term Debt Total748.1 K787.5 K4.9 M
Very volatile
Other Current Liabilities7.9 M11.6 M5.3 M
Slightly volatile
Total Current Liabilities25.4 M28.4 M15.7 M
Slightly volatile
Other Liabilities35.1 M33.4 M11.6 M
Slightly volatile
Property Plant And Equipment Net1.2 M1.2 M7.2 M
Slightly volatile
Current Deferred Revenue8 M5.5 M4.5 M
Slightly volatile
Accounts Payable6.8 M10 M4.5 M
Slightly volatile
Cash43.4 M45.6 M71.8 M
Pretty Stable
Non Current Assets Total2.1 M2.2 M8 M
Slightly volatile
Non Currrent Assets Other836.3 K640.8 K660.8 K
Slightly volatile
Other Assets0.860.91 M
Pretty Stable
Long Term Debt778.9 K819.9 K2.9 M
Slightly volatile
Cash And Short Term Investments43.4 M45.6 M71.8 M
Pretty Stable
Net Receivables17.9 M27.2 M13 M
Slightly volatile
Common Stock Shares Outstanding15.1 M14.4 M3.9 M
Slightly volatile
Long Term Debt Total778.9 K819.9 K2.9 M
Slightly volatile
Liabilities And Stockholders Equity139.4 M94.9 M103.8 M
Slightly volatile
Non Current Liabilities Total5.7 M6 M59.9 M
Slightly volatile
Capital Surpluse230.1 M457 M162 M
Slightly volatile
Other Current Assets14 M19.9 M8.8 M
Slightly volatile
Total Liabilities40.5 M28.2 M75.8 M
Slightly volatile
Property Plant And Equipment Gross7.6 M8 M9.7 M
Slightly volatile
Total Current Assets125 M92.8 M95.1 M
Slightly volatile
Non Current Liabilities Other7.7 M6.5 M5.7 M
Slightly volatile
Net Working Capital99.6 M64.4 M79.4 M
Slightly volatile
Property Plant Equipment13 M20.7 M9.7 M
Slightly volatile
Common Stock Total Equity3.5 K5.8 K3 K
Slightly volatile
Capital Stock1.1 K1.1 K2.7 K
Pretty Stable
Common Stock1.1 K1.1 K2.7 K
Pretty Stable
Capital Lease Obligations748.1 K787.5 K5.7 M
Slightly volatile
Short and Long Term Debt1.3 M1 M1.4 M
Pretty Stable
Short Term Debt943.9 K993.6 K2.9 M
Slightly volatile

Hookipa Pharma Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.9 M3.2 M1.8 M
Slightly volatile
Interest Expense1.7 K1.8 K541 K
Slightly volatile
Selling General Administrative16.6 M23.3 M11.3 M
Slightly volatile
Other Operating Expenses78.6 M109.7 M49.7 M
Slightly volatile
Research Development60.4 M78.8 M38.1 M
Slightly volatile
Cost Of Revenue2.4 M2.5 M8.5 M
Pretty Stable
Total Operating Expenses30.9 M32.5 M38.4 M
Slightly volatile
Reconciled Depreciation2.9 M3.2 M1.7 M
Slightly volatile
Total Other Income Expense Net8.6 M9 M5.3 M
Slightly volatile
Selling And Marketing Expenses2.8 M4.1 M2.5 M
Slightly volatile
Non Operating Income Net Other6.9 M8.2 M9.4 M
Slightly volatile

Hookipa Pharma Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock60.2 M86.6 M61.1 M
Pretty Stable
Stock Based Compensation4.5 M2.3 M2.7 M
Slightly volatile
Begin Period Cash Flow93.2 M135.1 M58.7 M
Slightly volatile
Depreciation2.9 M3.2 M1.8 M
Slightly volatile
Capital Expenditures211.9 K223.1 K2.3 M
Pretty Stable
End Period Cash Flow43.6 M45.9 M72 M
Pretty Stable
Change To Netincome5.4 M6 M3.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.630.663.628
Pretty Stable
Days Sales Outstanding402226351
Very volatile
Stock Based Compensation To Revenue0.05010.05270.1744
Pretty Stable
Capex To Depreciation0.0770.0812.17
Slightly volatile
Payables Turnover0.350.363.9032
Very volatile
Sales General And Administrative To Revenue0.50.530.8844
Slightly volatile
Research And Ddevelopement To Revenue1.71.793.0141
Very volatile
Capex To Revenue0.00480.00510.24
Slightly volatile
Cash Per Share3.463.64358
Slightly volatile
Days Payables Outstanding1.1 K1 K986
Slightly volatile
Income Quality1.671.591.0113
Slightly volatile
Net Debt To EBITDA1.041.092.9135
Slightly volatile
Current Ratio7.283.7610.9041
Slightly volatile
Receivables Turnover0.871.671.0946
Pretty Stable
Capex Per Share0.01690.01788.496
Slightly volatile
Revenue Per Share3.834.0346.2592
Slightly volatile
Interest Debt Per Share0.07640.080426.7581
Slightly volatile
Debt To Assets0.01160.01220.0475
Slightly volatile
Days Of Payables Outstanding1.1 K1 K986
Slightly volatile
Ebt Per Ebit0.680.760.8562
Slightly volatile
Quick Ratio7.443.7610.9785
Slightly volatile
Net Income Per E B T1.11.151.0161
Slightly volatile
Cash Ratio1.761.858.9989
Slightly volatile
Days Of Sales Outstanding402226351
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.221.151.1182
Pretty Stable
Fixed Asset Turnover39.0337.178.1506
Slightly volatile
Debt Ratio0.01160.01220.0475
Slightly volatile
Price Sales Ratio0.630.663.628
Pretty Stable
Asset Turnover0.50.480.18
Slightly volatile

Hookipa Pharma Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap27.5 M29 M162.4 M
Slightly volatile

Hookipa Fundamental Market Drivers

Hookipa Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Hookipa Pharma Financial Statements

Hookipa Pharma investors utilize fundamental indicators, such as revenue or net income, to predict how Hookipa Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M8 M
Total Revenue50.5 M53.1 M
Cost Of Revenue2.5 M2.4 M
Stock Based Compensation To Revenue 0.05  0.05 
Sales General And Administrative To Revenue 0.53  0.50 
Research And Ddevelopement To Revenue 1.79  1.70 
Revenue Per Share 4.03  3.83 
Ebit Per Revenue(1.05)(1.11)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
How To Invest In Hookipa
Details
Is Hookipa Stock a good investment?
Details
What is Hookipa Pharma's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Hookipa Pharma Correlation against competitors.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.83)
Revenue Per Share
0.747
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.45)
Return On Equity
(1.06)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY